NASAL SPRAY: GAME-CHANGER FOR ERECTILE DYSFUNCTION

madman

Super Moderator
US launch 2026!

UP YOUR NOSE AND UP IT GOES LOL!

* It’s also gearing up to launch a new product Roxus, another nasal spray which could help gain access to the US healthcare market





Tylah Tully chats with LTR Pharma (ASX:LTP) executive chairman Lee Rodne about its successful pre-Investigational New Drug Application meeting with the US FDA, a major milestone in the development of its erectile dysfunction product SPONTAN.It’s also gearing up to launch a new product Roxus, another nasal spray which could help gain access to the US healthcare market, valued over $6 billion dollars.
 
 

hCG Mixing Calculator

HCG Mixing Protocol Calculator

Beyond Testosterone Podcast

Online statistics

Members online
4
Guests online
144
Total visitors
148

Latest posts

Back
Top